Coronavirus Pandemic Could Delay Cannabis Legalisation in Europe and the US

Coronavirus Pandemic Could Delay Cannabis Legalisation in Europe and the US

The coronavirus pandemic is affecting all the aspects of modern life, and it may delay cannabis legalisation in the U.S. and Europe. As most of the world’s countries struggle to contain and fight the epidemic, marijuana legalisation may no longer be a priority for local authorities. Related: Legal Cannabis Sales Surging During Coronavirus Pandemic And that seems to be happening already in the U.S.   Coronavirus disrupts cannabis legalisation process in New York New York’s adult-use cannabis market is predicted to be worth billions in the near future. With an estimated number of 1.6 million cannabis consumers and over 65 million...

Legal Cannabis Sales Surging During Coronavirus Pandemic

Legal Cannabis Sales Surging During Coronavirus Pandemic

While the coronavirus pandemic is causing havoc in all market sectors, new data shows that legal cannabis markets in the U.S. saw a significant spike in sales in recent times. But even though consumers are currently stocking up on cannabis products, the fast-developing cannabis industry faces difficult times. Related: European Cannabis Discourse Is Mostly Canadian, and That’s a Problem   Coronavirus and cannabis hoarding is leading to supply bottlenecks in legal markets As the global toll of COVID-19 victims continues to rise and an increasing number of American states, as well as many European countries, are closing all non-essential businesses, cannabis...